Hillmen P, Jia X, Knight C, Sarda S, Mody-Patel N, Intorcia M, Dingli D. Model structure considerations for cost-effectiveness evaluation of C3 inhibitor pegcetacoplan versus C5 inhibitor in patients with paroxysmal nocturnal hemoglobinuria. Poster presented at the 2021 Virtual AMCP; April 2021.